News

Filter

Current filters:

Tykerb

1 to 9 of 76 results

Another blow for Pharma, as India revokes Tykerb patent

02-08-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) has confirmed that India's Intellectual Property Appellate…

Asia-PacificGlaxoSmithKlineLegalOncologyPatentsPharmaceuticalTykerb

GlaxoSmithKline's Tykerb/Tyverb and chemotherapy combo fails in gastric cancer

04-06-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) says that its study of Tykerb/Tyverb (lapatinib) in combination…

GlaxoSmithKlineOncologyPharmaceuticalResearchTykerbTyverb

BRIC countries' breast cancer market to see 8% annual growth to 2017

14-02-2013

The market for breast cancer therapies in the BRIC countries (Brazil, Russia, India and China) will grow…

GlaxoSmithKlineGlobalHerceptinMarkets & MarketingOncologyPharmaceuticalRocheTykerb

New Zealand to fund new cancer drugs Tykerb and Votrient

05-03-2012

The Pharmaceutical Management Agency of New Zealand, PHARMAC, says it is funding two new targeted cancer…

Asia-PacificGlaxoSmithKlineOncologyPharmaceuticalPricingRegulationTykerbVotrient

1 to 9 of 76 results

COMPANY SPOTLIGHT

Menarini

Back to top